---
title: "Ionis Pharmaceuticals concludes REVEAL study pivotal cohort enrolment"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292044496.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-07-07T10:02:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292044496.md)
  - [en](https://longbridge.com/en/news/292044496.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292044496.md)
---

# Ionis Pharmaceuticals concludes REVEAL study pivotal cohort enrolment

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [IONS.US](https://longbridge.com/en/quote/IONS.US.md)

## Related News & Research

- [Entropy Technologies LP Makes New $2.04 Million Investment in Ionis Pharmaceuticals, Inc. $IONS](https://longbridge.com/en/news/293897817.md)
- [Ionis Pharmaceuticals, Inc. $IONS Shares Acquired by California Public Employees Retirement System](https://longbridge.com/en/news/293717941.md)
- [Adult epilepsy market to reach $17.bn across 7MM by 2035](https://longbridge.com/en/news/293805836.md)
- [Magazine: Made in the USA](https://longbridge.com/en/news/293945661.md)
- [Sanofi abandons eczema drug approval efforts in another blow to OX40 class](https://longbridge.com/en/news/293763629.md)